Tekla Healthcare Investor...

16.86
-0.20 (-1.17%)
At close: Mar 04, 2025, 3:59 PM
16.88
0.12%
After-hours: Mar 04, 2025, 04:00 PM EST

Tekla Healthcare Investors Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 10.77M 10.29M 8.27M 6.48M 8.93M 7.6M 6.78M 5.62M 4.8M 4.33M 2.14M
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 10.77M 10.29M 8.27M 6.48M 8.93M 7.6M 6.78M 5.62M 4.8M 4.33M 2.14M
Operating Income -220.27K -1.19M -3.67M -6.23M -1.97M -2.87M -4.12M -5.16M -6.28M -7.85M -7.16M
Interest Income n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income 184.95M 56.33M -194.23M 155.18M 241.2M -145.29M 69.2M 121.28M -56.02M 96.17M 222.02M
Net Income 184.95M 56.33M -194.23M 155.18M 241.2M -145.29M 69.2M 121.28M -56.02M 96.17M 222.02M
Selling & General & Admin 10.99M 11.48M 11.94M 12.71M 10.9M 10.47M 10.9M 10.78M 11.08M 12.18M 9.3M
Research & Development n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 10.99M 11.48M 11.94M 12.71M 10.9M 10.47M 10.9M 10.78M 11.08M 12.18M 9.3M
Interest Expense n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 56.39K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 10.99M 11.48M 11.94M 12.71M 10.9M 10.47M 10.9M 10.78M 11.08M 12.18M 9.3M
Income Tax n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic) 52.13M 49.44M 47.34M 45.43M 43.87M 42.83M 42.22M 40.65M 39M 37.3M 35.82M
Shares Outstanding (Diluted) 52.13M 49.44M 47.34M 45.43M 43.87M 42.83M 42.22M 40.65M 39M 37.3M 35.82M
EPS (Basic) 3.55 1.14 -4.1 3.42 5.50 -3.39 1.64 2.98 -1.44 2.58 6.20
EPS (Diluted) 3.55 1.14 -4.1 3.42 5.50 -3.39 1.64 2.98 -1.44 2.58 6.20
EBITDA n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Depreciation & Amortization 220.27K 1.19M 3.67M 6.23M 1.97M 2.87M 4.12M 5.16M 6.28M 7.85M 7.16M